Expression of ubiquitin-specific protease 42 (USP42) mRNA was demonstrated to be higher in GC than in nontumorous tissues, and correlated with tumor size, TNM stage, lymph node metastasis, and OS of patients with GC [116]. This evidence concerns the gene USP42 and neoplasm.